Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
Howard Hughes Medical Institute · University of California, San Francisco · +13 more institutions
Abstract
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that enable uncontrolled growth and expansion to neighboring and distal tissues. The study of phylogenetic relationships between cancer cells provides key insights into these processes. Here, we introduced an evolving lineage-tracing system with a single-cell RNA-seq readout into a mouse model of Kras;Trp53(KP)-driven lung adenocarcinoma and tracked tumor evolution from single-transformed cells to metastatic tumors at unprecedented resolution. We found that the loss of the initial, stable alveolar-type2-like state was accompanied by a transient increase in plasticity. This was followed by the adoption of distinct…
Citation impact
- FWCI
- 29.08
- Percentile
- 100%
- References
- 154
Authors
23- DYDian Yang
Howard Hughes Medical Institute, University of California, San Francisco, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- MGMatthew G. Jones
QB3, Howard Hughes Medical Institute, University of California, San Francisco, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, University of California, Berkeley
- SNSantiago Naranjo
Massachusetts Institute of Technology
- WMWilliam M. Rideout
Massachusetts Institute of Technology
- KHKyung Hoi Min
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
Topics & keywords
- Biology
- Somatic evolution in cancer
- Lineage (genetic)
- Viral phylodynamics
- Epigenetics
- Tumor progression
- Epigenome
- Phenotype
Funding
- HHHoward Hughes Medical Institute
- DRDamon Runyon Cancer Research FoundationAward: DRG-2238-18
- HHHelen Hay Whitney Foundation
- LFLustgarten Foundation
- MIMassachusetts Institute of Technology
- LSLife Sciences Research Foundation
- JPJazz Pharmaceuticals
- RMRevolution Medicines
- RTRelay Therapeutics
- SASächsische Aufbaubank
- NINational Institutes of HealthAwards: R01CA211052, F31NS115380, U54CA224081, P30-CA14051, R01CA169338, R01CA204302, R01CA231300
- UOUniversity of California, San FranciscoAwards: T32GM007287, F31NS115380
- LCLudwig Center for Molecular Oncology
- LCLudwig Center at Harvard
- NCNational Cancer Institute
- NINational Institute of General Medical SciencesAwards: F32GM125247, F32GM128366